In the presence of CVD, the combined administration of estrogen, NSAID, and HIFblock brings Abeta from the AD-inducing level of 13 all the way back to the normative level of 2 (compare Rows 1 and 27 of Table 2). This evidence concerns the gene APP and Alzheimer disease.